Watch Eduardo Marbán, MD, PhD give a deep dive into the complexities of regenerative cardiovascular medicine and the future directions for cell therapies.
Dr. Marbán’s lab has found several noncoding RNA (ncRNA) species, including short Y RNAs, which themselves have intriguing biological actions. The ncRNA within extracellular vesicles can either be used as they occur naturally or serve as bioinspiration for new chemical entities. The next generations of cell-free biologics (extracellular vesicles and noncoding RNAs) may provide, or even transcend, the benefits of cell therapy without the intrinsic limitations.
Key Topics Include:
- Understand the current status of cell therapy for heart disease
- Review the mechanisms whereby cells exert their therapeutic benefits
- Explore the future of RNA drugs inspired by the contents of extracellular vesicles
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.
Resources
To retrieve a PDF copy of the presentation, click on the link below the slide player. From this page, click on the “Download” link to retrieve the file.
Presenters
Executive Director
Smidt Heart Institute
Cedars-Sinai Medical Center
Eduardo Marbán, MD, PhD, is an international leader in cardiology and a pioneering heart researcher. His 30-plus years of experience in patient care and research have led to key discoveries in gene- and cell-based therapies for heart disease.
Additional Content From American Physiological Society
Measurement of Cardiac Function Using Pressure-Volume Loops in Swine
Join Dr. Pedro Ferreira for a deep dive into his work using pressure-volume loops in large animal models of heart failure.
Peripheral and Cerebral Vascular Responses Following High-Intensity Interval Exercise
Dr. Bert Bond and Max Weston present an overview on their study investigating the effects high-intensity interval exercise has on cerebrovascular health.
APS Physiology in Disease Modeling and Drug Development Roundtable
Key opinion leaders in cardiovascular physiology and bioengineering discuss best practices and challenges when modeling cardiomyopathies and other cardiovascular diseases using stem cells, engineered tissues and other novel platforms.
Additional Content From European Council for Cardiovascular Research
Experimental Design Considerations to Optimize Chronic Cardiovascular Telemetry Studies
Phil Griffiths, PhD, presents a summary of chronic cardiovascular telemetry studies and considerations for experimental design.
Cardio-Renal-Lymphatic Disease
In this webinar, Dr. Giacomo Rossitto shares his research on heart failure and the related lymphatic dysfunction in patients.
Advances in Pressure-Volume Loop Data Collection: Tools, Training and Support
Join three experts in this technical overview of Pressure-Volume Loop collection and data analysis for cardiovascular research.
Related Content
Measurement of Cardiac Function Using Pressure-Volume Loops in Swine
Join Dr. Pedro Ferreira for a deep dive into his work using pressure-volume loops in large animal models of heart failure.
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection and Management
Artur Fedorowski, MD, PhD, describes cardiovascular dysautonomia in COVID-19 and the diagnostics behind detecting Long COVID or Post-acute Sequalae of COVID-19.
Neurovascular Coupling: Novel Insights from Studies in Awake Head-Fixed and Anesthetized Mice
Join Dr. Barbara Lind and Dr. Adrián Rodríguez-Contreras as they discuss neurovascular coupling in awake head-fixed and anesthetized mice, with a focus on the effects of anesthetics.